Definium Therapeutics, formerly known as Mind Medicine, is a clinical stage biopharmaceutical company founded in 2019, focused on developing innovative product candidates aimed at treating brain health disorders. The company is dedicated to becoming a global leader in the development and delivery of treatments that enhance patient outcomes by targeting key neurotransmitter pathways. With a commitment to expanding its global presence, Definium Therapeutics seeks high-impact individuals across various domains to join its patient-centric team, as it works on a pipeline of novel therapies, both with and without acute perceptual effects.